More on ORIC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ORIC Pharmaceuticals Inc. (NQ:ORIC)
Delayed: 12.35 -0.42 (3.29%)
Prev. Close $12.77  
Open$12.75 
52 Wk High$ 
52 Wk Low$ 
Day High$12.75 
Day Low$12.03 
P/E N/A  
EPS$ 
Volume946,201 

Friends, Peers and Foes (?): ARWR, CELC, KALV TVTX (more...)

Oct 14, 2026 08:48 AM ORIC Pharmaceuticals (ORIC) PT Raised to $26 at JPMorgan
Oct 5, 2026 04:03 PM ORIC Pharmaceuticals partners with Cancer Research UK on cancer drug
Oct 5, 2026 04:01 PM ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
Oct 5, 2026 06:09 AM Leerink Starts ORIC Pharmaceuticals (ORIC) at Outperform
Oct 2, 2026 05:51 PM Form 4 Oric Pharmaceuticals, For: Oct 01 Filed by: Heyman Richard A.
Oct 2, 2026 04:30 PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026 04:24 PM Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Oct 1, 2026 04:23 PM Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Sep 29, 2026 07:16 PM Form 4 Oric Pharmaceuticals, For: Sep 28 Filed by: Piscitelli Dominic
Sep 25, 2026 07:59 PM Form 4 Oric Pharmaceuticals, For: Sep 24 Filed by: Piscitelli Dominic
View All Articles

Entities mentioned with ORIC

View All Entities